2017
DOI: 10.2147/ijn.s146417
|View full text |Cite
|
Sign up to set email alerts
|

In vivo targeted gene delivery to peripheral neurons mediated by neurotropic poly(ethylene imine)-based nanoparticles [Corrigendum]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Previous research has employed the tetanus toxin to alter PLGA-PEG-biotin nanoparticles for targeting neuroblastoma cells [ 49 ]. Moreover, TTC-targeted polyethyleneimine and chitosan nanocomplexes have successfully been shown to deliver non-viral gene therapeutics to primary dorsal root ganglion (DRG) and nerve crush injury models, respectively [ 20 , 22 ]. Nevertheless, the next generation of delivery platforms must prioritize carrying diverse payloads, enhancing systemic circulation, facilitating surface modification and synthesis, ensuring biocompatibility, as well as augmenting functional recovery.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Previous research has employed the tetanus toxin to alter PLGA-PEG-biotin nanoparticles for targeting neuroblastoma cells [ 49 ]. Moreover, TTC-targeted polyethyleneimine and chitosan nanocomplexes have successfully been shown to deliver non-viral gene therapeutics to primary dorsal root ganglion (DRG) and nerve crush injury models, respectively [ 20 , 22 ]. Nevertheless, the next generation of delivery platforms must prioritize carrying diverse payloads, enhancing systemic circulation, facilitating surface modification and synthesis, ensuring biocompatibility, as well as augmenting functional recovery.…”
Section: Discussionmentioning
confidence: 99%
“…Several neurotrophic factors (brain-derived neurotrophic growth factor (BDNF) [ 14 ], nerve growth factor (NGF) [ 15 , 16 ], and neurotrophin-3 [ 17 ]) have shown promise in pre-clinical investigations by promoting synaptic plasticity along with neurite and axonal growth [ 18 ]. Extensive research on delivering nucleic acid-based pro-drugs via non-viral vectors to modulate the local expression of neurotrophins and promote functional recovery has also been conducted [ 19 , 20 ]. However, low systemic half-life, pleiotropic effects, reduced cargo size, immunogenic incompatibility, and toxic side effects of large doses hamper further clinical success [ 21 , 22 ].…”
Section: Introductionmentioning
confidence: 99%
“…Lopes et al constructed a nonviral neurotropic nanoparticle based on poly(ethylene imine), which demonstrates the capability to facilitate neuron-specific transfection following subcutaneous injection. 71 The targeting of nanoparticles to peripheral neurons is achieved using the neurotropic carboxylic fragment of the tetanus toxin (HC), which not only exhibits neurotropic properties but can also be retrogradely transported from neuron terminals to cell bodies. Following subcutaneous injection in the footpad of Wistar rats, the results obtained after five days reveal that 56% and 64% of L4 and L5 dorsal root ganglia neurons, respectively, exhibited expression of the reporter protein.…”
Section: Strategies For Nanoparticle-mediated Drug Deliverymentioning
confidence: 99%